Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin.
Meissner
H C
HC
Department of Pediatrics, Floating Hospital for Children, New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA. cmeissner@es.nemc.org
Welliver
R C
RC
Chartrand
S A
SA
Fulton
D R
DR
Rodriguez
W J
WJ
Groothuis
J R
JR
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D011379:Prognosis; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology*; D012307:Risk Factors
D016756:Immunoglobulins, Intravenous